Hikma Pharmaceutical reported 652M in Cost of Sales for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Artemis Alpha ATS:LN 632K 37K
AstraZeneca AZN:LN 2279M 790M
Bayer BAYN:GR € 5176M 1491M
Fresenius FRE:GR € 7162M 92M
Fresenius Medical Care FMS:US $ 3290.27M 37.59M
Galapagos GLPG:NA 2.91M 1.94M
GlaxoSmithKline GSK:LN 3645M 30M
GRIFOLS GRF:SM € 771.1M 119.7M
H. Lundbeck A/S LUN:DC 845M 155M
Hikma Pharmaceutical HIK:LN 652M 52M
Lonza Group LONN:SW 1.8B 301M
Merck MRK:GR € 1987M 28M
Orion ORNBV:FH 106.1M 16.8M
Recordati REC:IM 115.48M 756K